Introduction {#Sec1}
============

In 2016, sepsis and septic shock was re-documented as fatal organ dysfunction caused by infection-induced host response disorders^[@CR1]^. Infectious shock is a subtype of sepsis; its circulation abnormalities significantly increase the mortality rate. Low blood volume, antihypertensive drugs needed to maintain MAP ≥ 65 mmHg and serum lactic acid \>2 mmol/L can confirm septic shock. The definition was updated to facilitate rapid identification and timely treatment. Despite the continuous progress of awareness and intervention, the mortality rate of septic shock is approaching 40% or more^[@CR2]^. Infectious shock exists in the presence of imbalance of oxygen supply and demand as well as tissue hypoxia, early improvement of tissue hypo-perfusion is key to the treatment, a specific cluster treatment program was recommended in the guidelines of sepsis rescue action^[@CR3]^. Central venous oxygen saturation as one of the key goals of early goal management is widely used to guide resuscitation therapy for better tissue perfusion. In fact, normal ScvO~2~ does not exclude tissue hypo-perfusion^[@CR4],[@CR5]^. Carbon dioxide partial pressure difference is proportional to carbon dioxide production, and is inversely proportional to cardiac output, its normal value is 2\~5 mmHg, CO of more than 6 mmHg means that peripheral blood flow is not sufficient to clear out carbon dioxide^[@CR6]^. Numerous studies suggest that partial pressure difference of carbon dioxide may be an indicator to improve tissue perfusion for guiding early resuscitation of sepsis^[@CR7]--[@CR9]^. The use of continuous ultrasonic cardiac output monitor (USCOM), which is noninvasive and widely used in the severely sick patients, is convenient, fast and reproducible to monitor hemodynamics and to guarantee the accuracy of cardiac output and cardiac index^[@CR10]^. This study was conducted to investigate the relationship between (*p*(cv-a)CO~2~) and USCOM-measuring CI in patients with septic shock.

Patients and Methods {#Sec2}
====================

Jan 2016 Through Dec 2017, 66 patients with septic shock were admitted into the severe medical department of Beidaihe Hospital and North China Petroleum Administration General Hospital (ICU), those patients who undertook early fluid resuscitation in 6 hours and got the value of ScvO~2~ ≥ 70% were included in this retrospective study following the criteria: (1) met the diagnostic criteria of septic shock issued by international sepsis and septic shock treatment guidelines for septic shock in 2011^[@CR3]^; (2) early fluid resuscitation was conducted following the cluster treatment program of the sepsis action guideline. According to the guideline, the early goal-oriented treatment was applied in our unit. (3) ScvO~2~ ≥ 70% was achieved 6 hours after resuscitation; (4) ≥18 years old. Patients with incomplete data were excluded. Baseline venous and arterial blood gas analysis was measured every 6 hours in 24 hours. USCOM was used to measure CI, its probe was placed on the sternum or the supra-clavicular fossa to obtain the strongest signal, and measurement was taken for 3 consecutive times, each deviation did not exceed 10% to take the average of CI. This study was approved by Ethics Committees of Baidaihe Hospital and North China Petroleum Hospital. Informed consents were obtained from the patients' family. All procedures followed were in accordance with the ethical standards of responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

The patients' age, sex, diagnosis, APACHE IIscore were obtained. Early fluid resuscitation was started, time points of 0, 6, 12, 18, 24 hours after resuscitation were T0, T6, T12, T18, T24. Data like heart rate (HR), MAP, CVP, *p*(cv-a)CO~2~, CI and ScvO~2~ was collected at each time point. *p*(cv-a)CO~2~ was the difference between *p*cvCO~2~ and *p*aCO~2~, the normal value was less than 6 mmHg. The cut-off value of *p*(cv-a)CO~2~ at T0 was 6 mmHg, the group with \<6 mmHg or with ≥6 mmHg were low *p*(cv-a)CO~2~ group (T0) or high *p*(cv-a)CO~2~ group. Based on the hemodynamic data, the relationship between CI and *p* (cv-a)CO~2~ was analyzed.

Statistical {#Sec3}
-----------

All numeration variables were stated as median, and continuous variables were presented as means ± standard deviation and tested by normal distribution and analyzed by One-Way ANOVA; sampling rates were analyzed with x^2^ test, the correlation between CI and *p*(cv-a)CO~2~ and ScvO~2~ was analyzed by the Spearman test, the diagnostic characteristic curve (ROC curve) was used to evaluate the diagnostic value of the parameters, the value of *p* \< 0.05 was set as significant difference. All data was analyzed by statistical software SPSS22.0 (IBM Corp, Armonk, NY, USA).

Results {#Sec4}
=======

For the low *p*(cv-a)CO~2~ group, 20 male and 15 female patients aged 64.9 ± 12.5 years, the number of patients with ScvO~2~ ≥ 70% at T0 was 24 (68.6%). For the high *p*(cv-a)CO~2~ group, 18 male and 13 female patients aged 65.5 ± 10.4 years, the number of patients with ScvO~2~ ≥ 70% at T0 was 16(51.6%). At T6, the number of patients with *p*(cv-a)CO~2~ ≥ 6 mmHg in the low *p* (cv-a)CO~2~ group was 3(8.6%), while this number in the high *p*(cv-a)CO~2~ group was 17(54.8%), the total number of patients with *p*(cv-a)CO~2~ ≥ 6 mmHg was 20, account for 30.3% of all patients. There were no significant differences in age, sex and APACHEIIscore between two groups (*p* \> 0.05) (Table [1](#Tab1){ref-type="table"}), and no difference for patients with ScvO~2~ ≥ 70% (*p* \> 0.05), no difference for infection sites including lung, peritoneal cavity, urinary system and other sites. For HR, MAP, CVP, there were no significant differences between two groups (*p* \> 0.05), 28-day mortality rate was different, which was 38.7% (12/31)for high *p*(cv-a)CO~2~ group and 22.8% (8/35) for low *p*(cv-a)CO~2~ group (*p* \> 0.05). There were significant differences for CI at respective time point between two groups (*p* \< 0.001) (Table [2](#Tab2){ref-type="table"}). The value of *p*(cv-a)CO~2~ was evaluated by ROC curve to predict CI (Fig. [1](#Fig1){ref-type="fig"}). Area under ROC curve was 0.782, the sensitivity was 0.857 and the specificity was 0.668 when *p*(cv-a)CO~2~ was ≤5.55 mmHg to follow CI ≥ 2.2 L/(min•m^2^) (Fig. [2](#Fig2){ref-type="fig"}).Table 1Characteristics of patients at T0.Low *p*(cv-a)CO~2~ (n = 35)High *p*(cv-a)CO~2~ (n = 31)*p*Age (years)64.9 ± 12.565.5 ± 10.40.827Gender(male/female)20/1518/130.941BMI(kg/m^2^)21.4 ± 6.123.4 ± 7.10.079ScvO~2~ ≥ 70%(%)24 (68.6)16 (51.6)0.209APACHE II21.7 ± 4.321.8 ± 3.20.901**Diagnosis n (%)**Pneumonia23(66)21(68)0.862Abdominal infection6(17)5(16)0.912Urinary tract infection2(6)2(6)0.900Others4(11)3(10)0.818HR^\*^(beats/min)1071130.761MAP(mmHg)56 ± 854 ± 80.221CVP(mmHg)5 ± 24 ± 30.075CI(L/min·m^2^)4.1 ± 1.42.4 ± 0.6\<0.001*p*(cv-a)CO~2~/mmHg3.3 ± 1.37.9 ± 1.9\<0.001ScvO~2~(%)71 ± 669 ± 50.09628-day mortality rate22.8% (8/35)38.7% (12/31)\>0.05BMI: body mass index, APACHE: acute physiology and chronic health evaluation, HR: heart rate, MAP: mean arterial pressure, CVP: central venous pressure, CI: cardiac index, *p*(cv-a)CO~2:~ central venous-arterial carbon dioxide difference, ScvO~2:~ central venous oxygen saturation. HR\* presented as median.Table 2Hemodynamic parameters at each time point.Low*p* (cv-a)CO~2~High*p* (cv-a)CO~2~T0T6T12T18T24T0T6T12T18T24HR12210810098110122114110110106*p\**0.7610.1110.1070.2050.060MAP(mmHg)56 ± 873 ± 1078 ± 1281 ± 1584 ± 1754 ± 869 ± 1373 ± 1076 ± 1177 ± 12*p\**0.2210.1550.1290.1230.062CVP (mmHg)5 ± 210 ± 310 ± 310 ± 310 ± 34 ± 39 ± 39 ± 39 ± 310 ± 3*p\**0.0750.1970.1720.5170.677CI (L/min.m^2^))4.1 ± 1.44.4 ± 0.94.1 ± 1.34.0 ± 1.34.2 ± 1.42.4 ± 0.62.8 ± 0.72.9 ± 0.62.7 ± 0.82.9 ± 0.8*p\**\<0.001\<0.001\<0.001\<0.001\<0.001ScvO~2\ (%)~71 ± 675 ± 374 ± 673 ± 675 ± 469 ± 574 ± 473 ± 575 ± 575 ± 5*p\**0.0960.2980.3210.1830.684***p\****: parameters compared respectively at each time point.Figure 1Correlation of CI and *p*(cv-a)CO~2~, R^2^ = 0.536, *p* \< 0.001.Figure 2ROC curve for *p*(cv-a)CO~2~ to predict CI with \>2.2 L/(min·m^2^), Area under ROC curve was 0.782, the sensitivity was 0.857 and the specificity was 0.668.

Discussion {#Sec5}
==========

*p*(cv-a)CO~2~ is well-accepted to study carbon dioxide partial pressure difference^[@CR8]^, the combination of *p*(cv-a)CO~2~ and ScvO~2~ can guide therapeutic shock resuscitation to avert fluid overload due to pseudo-normalization of ScvO~2~. The clinical significance of *p*(cv-a)CO~2~ is as follows: (1) The initial increase of *p*(cv-a)CO~2~ is more than 6 mmHg, which indicates that the blood flow may be insufficient, even if the microcirculation parameters (including ScvO~2~) are normal. CO should be increased to improve tissue perfusion, especially in the presence of hypoxia (elevated lactate). (2) normal *p*(cv-a)CO~2~ range (\<6 mmHg) is indicative that blood flow from the peripheral cycle clears out carbon dioxide, improving heart output is not the preferred treatment, even if tissue hypoxia exists^[@CR9]^. In our study, under the condition of ScvO~2~ compliance after resuscitation, most patients achieved *p*(cv-a)CO~2~ ≥ 6 mmHg at T0, T6. Although after the early fluid resuscitation treatment, there are still some patients with insufficient venous blood flow to clear out CO~2~ in the peripheral tissue. In the early resuscitation phase, those patients may need more active and longer duration of resuscitation therapy. Leisman *et al*. reported that fluid resuscitation was started in these patients in 30 min, the mortality rate was only 13.3%, and that initiation of fluid resuscitation was delayed 30 min, mortality increased over the prolonged fluid resuscitation^[@CR10]--[@CR13]^. Numerous studies have shown that *p*(cv-a)CO~2~ can be one of the goals of resuscitation treatment. There were no significant differences in hemodynamic parameters respective of CI and *p*(cv-a)CO~2~ between two groups in our study, in the process of resuscitation, cardiac output is clinically lower than normal, ScvO~2~ cannot be low. When shock occurs, mitochondria cannot use oxygen for energy metabolism, it is cytopathic hypoxia, although this stage ScvO~2~ can be increased, or even abnormally increased, unrelated to more oxygen transport, it is still an important manifestation of tissue hypoxia that predicts a poor prognosis^[@CR4]^. CI is conveniently measured with USCOM, which is a new non-invasive hemodynamic monitoring method that is continuous Doppler technology to obtain hemodynamic parameters. Compared with floating catheters and pulse-indicated continuous cardiac output with invasive operations and catheter-related complications^[@CR14]^, USCOM is increasingly applied in the clinical practice due to its rapidity and reproducibility to monitor hemodynamics and to guarantee the accuracy of CO and CI. *p*(cv-a)CO~2~ is inversely proportional to CO, and *p*(cv-a)CO~2~ is elevated in case of tissue CO~2~ retention when cardiac function is not good enough to provide adequate venous blood flow. Our report demonstrated that CI in some patients was still low after successful resuscitation. Rivers *et al*. reported that the outcomes for an early goal-oriented treatment for sepsis and septic shock, mortality rate was decreased by 15% of patients^[@CR15]--[@CR17]^. Ho *et al*. reported that the application of key point control strategies improved the compliance of clinicians with guidelines for cluster therapy for septic shock, the ICU stay time was reduced from 9.8 days to 7.2 days, in-hospital mortality rate went down from 40.0% to 23.1%^[@CR12]^, our study substantiated that *p*(cv-a)CO~2~ was negatively correlated with CI, not correlated with ScvO~2~. Valle'e *et al*. reported that 6 mmHg as the threshold was predictive of insufficient early resuscitation for patients to reach ScvO~2~ ≥ 70%^[@CR18]--[@CR20]^. Mallat *et al*. also reported that CI and *p*(cv-a)CO~2~ were negatively correlated^[@CR13]^, our result resembled these documents though our limitation in this report was mainly due to small sample size. Low CI means that venous blood flow is not sufficient to wash out CO~2~ in the peripheral tissue^[@CR14]^, Therefore, simultaneous monitoring of CI and *p*(cv-a)CO~2~ is beneficial to determine cardiac function status and whether adequate venous blood flow is provided to meet the need of CO~2~ clearance from peripheral tissues.

Conclusion {#Sec6}
==========

In sepsis, CI and *p*(cv-a)CO~2~ are negatively correlated, the latter is useful parameter to evaluate cardiac output in the course of shock resuscitation.
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